Health Information Technology Archives - Policy@Intel

Innovation in healthcare can revolutionize patient outcomes By Mário Romão, Health and Data Policy at Intel The statistics are sobering. More than 1 in 3 men and women will be diagnosed with cancer at some point during their lifetimes. Efforts in science, medicine and public health have led to a decrease of the mortality rate in the US (1.8 percent and 1.4 percent per year from 2006-2015,...
read more
NITI Aayog, TIFR and Intel Establish International Center for Transformative Artificial Intelligence By Derek Waxman, Director, Public Policy, Artificial Intelligence and Client Computing NITI Aayog, Intel and TIFR collaborate to set up a model International Center for Transformative Artificial Intelligence (ICTAI) aiming to solve major challenges in India. The center will focus on application-based AI research in healthcare, agriculture and smart mobility. NITI Aayog, Intel and the Tata Institute of Fundamental Research...
read more
Europe, AI, and Genomics – Big Topics Discussed at Digital Day 2018 By Mario Romao, Global Director, Health and Data Policy April 10th was a big day for the digital ambitions of Europe. We saw leaders from 25 nations signing a Declaration of Cooperation on Artificial Intelligence (AI), committing to join forces to advance research and deployment of AI, without forgetting the social, economic, ethical, and legal aspects. And a couple of...
read more
How to Use Artificial Intelligence in Healthcare While Protecting Privacy By David Hoffman, Associate General Counsel and Global Privacy Officer Technological advancements in health IT have created tremendous possibility for improved efficiency and better interoperability, empowering patients to play a more dynamic role in their healthcare. Increased access to data that can predict health outcomes, and more effective analytical capabilities including artificial intelligence, create tremendous potential to solve some of...
read more
2018 Bodes Well for Telehealth and Remote Patient Monitoring By Mario Romao, Global Director, Health and Data Policy If 2017 ended on a high for telehealth and remote patient monitoring, the start of 2018 also did not disappoint. Indeed, on Feb 9, the Bipartisan Budget Act of 2018 was signed into law. This bill, which provides a budget agreement for 2018-2019, also includes a number of policy provisions in support...
read more
Winds are Changing for Remote Patient Monitoring In my last blog post I referenced the launch of the Intel® Health Application Platform for remote healthcare and also the recent solicitation for comments on “Current Year 2018 Revisions to Payment Policies under the Physician Fee Schedule” (PFS), in which the Centers for Medicare 7 Medicaid Services (CMS) asked for input on how to pay for remote patient monitoring...
read more
Intel launches the Health Application Platform to Provide Better and More Efficient Care Intel announced the launch of the Intel® Health Application Platform, software that, when coupled with an Intel-architecture-based design specification implemented by a third-party hardware vendor, can help enable healthcare solution providers to securely and reliably deliver distributed healthcare services and a new standard for remote patient care[1]. As digitization of healthcare systems progresses, more data about patients’ conditions are routinely...
read more
Advancing Precision Medicine, Promoting Better Patient Outcomes The U.S. is making exciting strides in precision medicine. Yesterday, Intel and the Broad Institute of Harvard and MIT announced revolutionary developments advancing the use of high-performance computing for genomics analytics that will accelerate precision medicine. Together we have created a new architecture, the Broad-Intel Genomics Stack (BIGstack), that dramatically improves the genomic analytics pipeline and supports data volumes at...
read more
21st Century Cures to advance precision medicine. The 21st Century Cures Act will dramatically advance precision medicine, accelerating medical discovery and improving outcomes for patients across the United States. The Act brings together the computational expertise of the Department of Energy and clinical expertise of the National Institutes of Health to enhance genomic analytics and opens the door for technologies such as whole genomic sequencing (WGS), which...
read more
Precision Medicine Is the Next Global Space Race. Will the US Lead? By: Alice B. Borrelli, Global Director for Healthcare Policy, Intel Kathleen Lynch, Senior Director, Global Government Affairs & Public Policy, Illumina DNA sequencing is advancing faster than nearly any other technology in history—and it’s setting off the next global space race. Nations that come out on top in precision medicine will be the ones to lead the world in curing...
read more

Subscribe to our RSS Feed